PROCEDURAL SOLUTIONS
Benign prostatic hyperplasia—also called BPH—is a condition in men in which the prostate gland is enlarged and not cancerous. It can lead to lower urinary tract symptoms (LUTS). BPH affects about 50% of men between the ages of 51 and 60 and up to 90% of men older than 80.1
Prostatic Artery Embolization (PAE) is a minimally invasive option to treat BPH and can be performed via radial or femoral access.
Peripheral microcatheter offered in the optimal length for radial access in pelvic procedures with the ability to deliver embolic materials.3
Designed with large 0.019" inner lumen to enhance access to small peripheral vessels and confidently deliver embolotherapy.2-3
Available in 0.016" and 0.018" and a variety of tip shapes to help navigate and select even the most acutely angled vessels.
Keep your patients in mind as you embolize. The unique formulation of HYDROPEARL Microspheres was exclusively developed to offer controlled and targeted embolization. HYDROPEARL Microspheres are tightly calibrated and indicated for embolization of prostatic arteries (PAE) for symptomatic BPH. This precise calibration may allow more predictable and targeted embolization.3-5
Offering a unique cross-sectional coverage, AZUR™ CX provides a stable and permanent platform for small vessel embolization. AZUR™ CX is engineered with Hydrogel, creating a solid core when expanded for a stable, non-absorbable mechanical occlusion.6-9
Terumo Interventional Systems is the pioneer in radial access with solutions that deliver economic value for providers and enhanced outcomes for their patients.
Terumo Learning EDGE™ has procedural training that will help you advance your practice and optimize patient outcomes. Learn more about our offerings for Prostate Artery Embolization.
Join Dr. Ari Isaacson, Dr. Aaron Fischman, and Dr. Justin McWilliams as they discuss complex and challenging endovascular interventions for PAE. Understand how to overcome complex anatomy, access challenges, and gain insight into tips and tricks used by the experts.
Watch as Scott Schwartz, MD of Wayne State University School of Medicine and Henry Ford Health System, Detroit, MI presents on radial access and equipment for prostate artery embolization. He shares his case experience, equipment preferences and disease information on PAE. This presentation was originally presented at STREAMSK in Washington, D.C. on January 27, 2019.
Join Dr. Keith Pereira and Dr. Aaron Fischman as they discuss pushing the boundaries of endovascular interventions for prostate artery embolization, address diagnosis and treatment algorithms for the patient with BPH, and gain insights on device selection, microcatheter and wire manipulation, methods of access and intervention, and review the patient outcomes data in this fast-growing endovascular procedure.
Comparison of clinical and functional outcomes of prostatic artery embolization (PAE) with those of transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
An assessment of the safety and efficacy of PAE compared with a sham procedure in the treatment of LUTS/BPH.
Meta-analysis of available data on prostatic artery embolization (PAE)
Anatomy and imaging findings of the prostatic arteries (PAs) on multirow-detector pelvic computed tomographic (CT) angiography and digital subtraction angiography (DSA) before embolization for symptomatic benign prostatic hyperplasia (BPH).
The feasibility, safety and short-term results of prostatic artery embolization (PAE) performed with adjunctive coil embolization of the main prostatic arteries (PA) following particle embolization.
